Mifepristone Manufacturers Move to Block GOP Lawsuit Seeking Nationwide Telehealth Abortion Ban

(AND THE MISOGYNIST, PATRIARCHAL, CHRISTOFASCIST, THEOCRATIC, WOMAN-HATING WAR ON WOMEN CONTINUES APACE)



Mifepristone Manufacturers Move to Block GOP Lawsuit Seeking Nationwide Telehealth Abortion Ban
PUBLISHED 2/11/2026 by Carrie N. Baker


“Attacks on mifepristone are not about safety—they are part of an anti-science, autocratic playbook that is unfolding across the nation that threatens people, families and communities,” said Democracy Forward president Skye Perryman.



Former Louisiana Attorney General Jeff Landry testifies in front of the U.S. House on March 30, 2023. As AG, Landry joined a multistate lawsuit led by Mississippi and other antiabortion officials that sought to roll back the FDA’s expanded approval of mifepristone. The state’s current AG, Liz Murrill, has continued and escalated these efforts. (Tom Williams / CQ-Roll Call, Inc via Getty Images)

The attorneys general of Louisiana, Idaho and Missouri filed a lawsuit in October 2025 in a Louisiana federal court, seeking to overturn the U.S. Food and Drug Administration’s 2023 decision to allow telehealth abortion. Represented by the antiabortion juggernaut (and ironically named) Alliance Defending Freedom, the Republican attorneys general inaccurately claimed the FDA had ignored the safety risks of easing access to mifepristone.
The lawsuit, Louisiana et al v. FDA, seeks to restore an outdated in-person dispensing requirement for mifepristone, used as part of a two-pill regimen for medication abortion, and block access to mifepristone through pharmacies and mail. The states have asked U.S. District Judge David Joseph, a Trump appointee, to issue a preliminary injunction blocking telehealth abortion and pharmacy dispensing of mifepristone while he weighs the merits of the case. In the first half of 2025, 27 percent of all abortions within the U.S. healthcare system were provided via telehealth. Telehealth abortion from out of states is a critical avenue of access for women living in states that restrict abortion providers located inside the states from providing abortion services. With telehealth abortion access on the line, mifepristone’s manufacturers are moving to join the lawsuit and defend access to medication abortion.

On Feb. 3, Danco Laboratories and GenBioPro—manufacturers of the brand-name and a generic of mifepristone—filed motions to intervene, opposing Louisiana’s request for a preliminary injunction and urging the court to dismiss the lawsuit. The drugmakers argue that mifepristone has a long-established safety record—proven safe beyond any doubt by over 100 peer-reviewed studies and 25 years of real-world use by more than 7.5 million women. GenBioPro explained its reasons for filing the motion. “We are increasingly concerned by extremists’ complete disregard for the large body of scientific evidence supporting mifepristone’s use and safety,” said GenBioPro CEO Evan Masingill. “We will not stand by while politically motivated efforts put Americans’ access to medication abortion in jeopardy.”
Generic mifepristone tablets, 200 mg, from GenBioPro, the first FDA-approved generic medical abortion pill in the U.S. (Courtesy of GenBioPro)

GenBioPro is represented by Democracy Forward Foundation and Arnold & Porter, who warned about the dangers of this attack on the FDA’s authority to make decisions based on science.“Attacks on mifepristone are not about safety—they are part of an anti-science, autocratic playbook that is unfolding across the nation that threatens people, families and communities,” said Skye Perryman, president and CEO of Democracy Forward. “In this matter, it isn’t just mifepristone—which has a decades-long demonstrated safety profile—that is being threatened in pursuit of ideology and unbridled power, it is also our nation’s science-based drug approval system.”

. . . .

When the Supreme Court overturned Roe v. Wade, the Supreme Court said the power to regulate abortion would lie in the states, yet this case is about a handful of conservative states trying to ban telehealth abortion nationwide, including in states that currently allow it, by forcing the FDA to change its science-based approach to mifepristone. “The overwhelming majority of Americans support the legal right to abortion and understand that healthcare decisions should be made by people, not politicians,” said Perryman. “Yet, ideologically extreme organizations have repeatedly tried to weaponize our courts to strip people of essential healthcare and put all Americans in harm’s way.”

https://msmagazine.com/2026/02/11/mifepristone-manufacturers-move-to-block-gop-lawsuit-seeking-nationwide-telehealth-abortion-ban/